Cheng et al. examined LGALS3 mRNA expression in mononuclear cells from bone marrow (BM) of patients with newly diagnosed non-acute promyelocytic leukemia (non-APL; non-M3 AML) before treatment and correlated the findings with the patients’ clinical characteristics and outcomes. The gene discussed is LGALS3; the disease is acute promyelocytic leukemia.